Tonix Pharmaceuticals Expands Pipeline with Mid-Stage Biologic Candidate
Tonix Pharmaceuticals (NASDAQ:TNXP) has announced that it has in-licensed a Phase 2 asset, TNX-1300 for treating cocaine intoxication. As quoted...
AzurRx BioPharma Reaches Enrollment Target for Phase II OPTION Clinical Trial
AzurRX BioPharma (NASDAQ:AZRX) has announced it has reached its enrollment target of 30 to 35 patients for its ongoing Phase...
Avricore Health Inc. Installs New CFO and Corporate Secretary
Avricore Health Inc. (TSXV:AVCR,OTCQB:AVCRF)(“Avricore Health”) is expanding its capacity to meet its objectives by adding Kevin Strong as Chief Financial...
Green Growth Brands to Hold Third Quarter Fiscal 2019 Earnings Conference Call on May 30, 2019
Green Growth Brands Inc. (CSE:GGB, OTCQB:GGBXF)today announced it will report results for the third quarter fiscal 2019, which ended March 31, 2019,...
Agile Therapeutics Announces FDA Acceptance of the NDA Resubmission of Twirla®
Agile Therapeutics (NASDAQ:AGRX) has announced that the US Food and Drug Administration (FDA) has accepted for review its new drug...
BrainsWay Announces its Multicenter Smoking Cessation Study Has Reached Target Enrollment
BrainsWay (NASDAQ:BWAY) has announced it has reached its target recruitment for its multicenter study for the safety and efficacy of...
Avadel Pharmaceuticals Receives FDA Acceptance for New Drug Application
Avadel Pharmaceuticals (NASDAQ:AVDL) has announced that the US Food and Drug Administration (FDA) has granted the company new drug application...